The Oncology Institute, Inc. (TOI) Misses Q3 EPS by 3c ; Offers Guidance

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $136.6 million versus the consensus estimate of $122.83 million.

Guidance 2025 :-

Revenue between $495 million to $505 million vs consensus $500.6 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%